The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies
  • Mind Cure Establishes Psychedelic Compound Research Program
  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
  • Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
  • Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
Psychedelic Stocks
Exploring the companies and themes that make up this emerging and exciting new sector

Delic Corp Commences Trading On CSE

2020-11-18 PSW Editor

Delic Corp is a Delaware-based psychedelics company that has gone public via RTO.

Psychedelic Drug Therapy: Cure Your Mind, Save Your Heart?

2020-11-18 Jeff Nielson

Will psychedelic drug therapies (simultaneously) save lives as they cure mental health disorders?

Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders

2020-11-18 PSW Editor

Numinus plans a "compassionate access" clinical trial of psilocybin to treat substance abuse.

More U.S. Military Funding For Psychedelic Drug R&D As PTSD Crisis Worsens

2020-11-16 Jeff Nielson

To commercialize psychedelic drugs, they first have to be legalized. In the United States, an important ally in this battle has surfaced: the DoD.

MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

2020-11-16 PSW Editor

Another incremental step forward in one of MindMed's leading psychedelics R&D initiatives.

Mind Cure Announces Non-Brokered Private Placement of up to $3 Million

2020-11-13 PSW Editor

Mind Cure Health is seeking to raise $3 million via the sale of 6.66 million units.

A Market Reality Check For Psychedelic Stocks

2020-11-11 Jeff Nielson

The Psychedelics Revolution is here to stay. The solutions of tomorrow are the investments of today.

Navy SEAL Foundation Contributes $50,000 to Support Major PTSD Study

2020-11-11 PSW Editor

The Navy SEAL Foundation (NSF) recently pledged one of the organization’s largest single grants in its 20-year history to support a major Post Traumatic Stress Disorder (PTSD) study.

Mind Cure Announces Hiring of Award-Winning Experimental Scientist Dr. Ryan Hartwell as Chief Science Officer

2020-11-10 PSW Editor

Mind Cure's new Chief Science Officer (CSO) brings experience in drug research as well as natural product development.

New Psychedelic Stocks: The Menu Is Getting Longer For Investors

2020-11-09 Jeff Nielson

Three new psychedelic stocks are trading publicly. One commenced trading last week, two more are coming this week.

COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care

2020-11-09 PSW Editor

Compass joins an international organization dedicated to advancing psychedelic drug research.

Entheon Biomedical Corp. (formerly MPV Exploration Inc.) Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange

2020-11-06 PSW Editor

Entheon Biomedical has announced that it expects to commence public trading on or about November 12th, symbol "ENBI".

  • Previous
  • 1
  • ...
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • ...
  • 73
  • Next
Join our Newsletter
 Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

2021-01-21
Mind Cure announces a CAD$10 million bought deal financing at a unit price of CAD$0.60. Proceeds will be directed toward product research development and related tech initiatives like its iSTRYM digital therapeutics platform.

Mind Cure Establishes Psychedelic Compound Research Program

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

Psychedelic Stocks
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2022, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor